Tecan’s Cavro® Omni Robot opens up new applications for modern circular dichroism
Publication date: 15 September 2011
Author: kdm communications limited
Tagged with: Lindsay Cole, Tecan
Tecan’s Cavro® Omni Robot has been incorporated into Applied Photophysics’ new protein discovery solution, the Chirascan™-plus CD Spectrometer.
Increasing throughput with the Tecan Cavro Omni Robot
This newly created system combines Tecan’s precise and reliable sample handling with excellent measurement reproducibility, opening up a wide range of circular dichroism (CD) applications for the first time.
The Cavro Omni Robot has enabled Applied Photophysics to automate sample preparation for CD, as Project Leader Lindsay Cole explained: “The Omni Robot is an open and malleable liquid handling component, and was very easy to incorporate into our system. It has eliminated the need to design and integrate our own fluidics, sample probe and injection port, as well as giving us a number of useful features – such as the sample level sensing – and the option to add other sample handling and preparation capabilities in the future.”
“Automation has significantly increased the practical throughput of the Chirascan, allowing unattended running with minimal user intervention and reducing labor requirements per measurement by 90 %. This, combined with the reliability and increased reproducibility offered by the Cavro Omni Robot, has greatly increased the appeal of CD as an analytical technique for proteins, particularly for the biopharmaceuticals development market.”
To find out more about Tecan’s Cavro Omni Robot, visit www.tecan.com/components
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content